Abstract-The relative importance of three enzymes, amastatin-sensitive amino peptidase, captopril-sensitive peptidyl dipeptidase A and phosphoramidon-sensitive endopeptidase-24.1 1, to inactivate two opioid peptides, [Met5]-enkephalin and [Met5]-enkephalin-Arg6, was investigated in three in vitro isolated preparations, guinea-pig ileum, mouse vas deferens and rat vas deferens, by estimating the magnitude of the enhancement of the inhibitory potency of the opioid peptide by each peptidase inhibitor. Results showed that the relative importance of the three enzymes in the inactivation of the opioid peptide, whether it was [Met5]-enkephalin or [Met5]-enkephalin-Arg6, in guinea-pig ileum was significantly different from that in either mouse vas deferens or rat vas deferens. Additionally, the relative impor tance of the three enzymes in the preparation, whether it was guinea-pig ileum, mouse vas deferens or rat vas deferens, in the inactivation of [Met5]-enkephalin was significantly different from that of [Met5]-enkephalin-Arg6. The significance of the presence of plural inactivating-enzymes for opioid peptides was discussed.
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nificant concentration difference of enke phalin between the surrounding organ bath and the vicinity of opioid receptors (1) (2) (3) . Therefore, these enzymes are suggested not only to inactivate the exogenously given enkephalin in the vicinity of opioid receptors but also to play important roles in the termination of the action on opioid receptors of the enkephalin released from presynaptic nerve terminals.
Moreover, enkephalin has been demon strated to be almost exclusively hydrolyzed by these three peptidases, since enkephalin remains intact almost totally after it is incubated with either ileal or striatal mem brane fractions of guinea-pig for 60 min at 37'C in the presence of three peptidase inhibitors, amastatin, thiorphan and captopril, although free tyrosine and the Tyr-Gly-Gly fragment are produced when the incubation mixture does not contain the peptidase inhibitor (4). However, the significance of the presence of plural inactivating peptidases for * To whom reprint requests should be addressed .
the opioid peptide is unclear at present. Since various opioid peptides other than enkephalins have been shown to be also inactivated by the enkephalin-hydrolyzing enzymes (5, 6) , it is probable that one opioid peptide is mainly inactivated by a particular enzyme while the other peptide is primarily inactivated by the other enzyme. Another possible interpretation for the presence of plural inactivating enzymes is that one enzyme plays a primary role in the inactivation of the opioid peptide in a particular tissue, while the other enzyme mainly inactivates the peptide in the other tissue. In order to test these two hypotheses, the relative importance of three enzymes tc inactivate two opioid peptides, In vitro isolated preparations: Male ICR JCL mice weighing 30-50 g, male Wistar rats weighing 200-400 g, and male Hartley guinea-pigs weighing 300-500 g were used for this study. The vasa deferentia from mice or rats, and the myenteric plexus-longi tudinal muscle strip of guinea-pig ileum were prepared and set up for electrical stimu lation as described previously (7) . The % inhibition of the stimulated muscle twitch produced by an opioid peptide was plotted against the log concentration of the opioid to estimate the IC50 (concentration of the opioid peptide to produce 50% inhibition of twitch). When the effect of a particular peptidase inhibitor on the inhibitory potency of an opioid peptide was examined, the IC50 values of the opioid before and after the addition of a particular peptidase inhibitor had been shown to be inhibited almost completely with either 100 , M of bestati n or 1 ,u M of amastatin, 1 u M of captopril, and either 1 /LM of thiorphan or 1 /cM of phosphoramidon, respectively (1-4). The reason for the use of amastatin and phosphoramidon instead of bestatin and thiorphan, respectively, in the present study was that amastatin was more potent and more soluble in water than bestatin (1), and phosphoramidon was more stable, more soluble in water and more selective than thiorphan (2, 8). Since captopril, an inhibitor of the enkephalin-hydrolyzing peptidyl dipep tidase A, was also soluble in water, the water solution which contained two or three inhibitors of enkephalin-hydrolyzing pep tidases could be made easily and employed in the present study because of its con venience. Either a peptidase inhibitor or the mixture of two or three peptidase inhibitors was given ten min before the opioid admin istration. The ratio of the potency and the % difference, shown in the tables, were calcu lated from the following formulas (Table 3) . Since the presence of the enzyme with low enkephalin inactivating activity might be difficult to be detected when the residual enzyme with high enkephalin-inactivating activity was not in hibited, the enkephalin-inactivating ability of captopril-sensitive peptidyl dipeptidase A was then examined in the rat vas deferens in which the residual two enzymes had been inhibited in advance.
The IC50 value of [Met5] enkephalin in the rat vas deferens pretreated with two peptidase inhibitors, amastatin and phosphoramidon, was slightly but signifi cantly higher than that pretreated with three peptidase inhibitors, amastatin, phos phoramidon and captopril ( in the rat vas deferens pretreated with any combi nation of two peptidase inhibitors, however, could be determined (Table 6) . Therefore, the effect of each peptidase inhibitor on the Table  6 ). The magnitude of the enhancement was the highest by amastatin, intermediate by captopril, and th.e lowest by phosphoramidon in rat vas deferens (Table 6) .
Among the data obtained in the present investigation, the ratio of the potency which was shown in Tables 1-6 is summarized in Table 7 The data in the present study, therefore, indicate that an enzyme in some preparations, like aminopeptidase in rat vas deferens, plays the primary role in the inactivation of many opioid peptides because of its very high activity against many substrates, while the relative importance of three enzymes to inactivate the opioid peptide may be deter mined by a given substrate in other prepara tions such as guinea-pig ileum and mouse vas deferens. Additionally, an enzyme in some preparations, like the endopeptidase-24.11 in guinea-pig ileum, is suggested to play no significant role to inactivate some opioid peptide like [Met5]-enkephalin-Arg6. More over, the enzyme, which plays no significant role in the inactivation of the opioid peptide, may play the primary role in the inactivation of neuropeptides other than opioid peptides, since coexistence in the same neuron of two peptides, which are therefore released into the same synaptic cleft, has been described (13) , and the enkephalin-inactivating enzyme has been reported to be able to hydrolyze the neuropeptide other than opioid peptides (8) . Thus, the significance of the presence of plural inactivating-enzymes for opioid peptides became partially clear in the present investigation.
